These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19191678)

  • 1. Treatment options for AIDS patients with progressive multifocal leukoencephalopathy.
    Hernández B; Dronda F; Moreno S
    Expert Opin Pharmacother; 2009 Feb; 10(3):403-16. PubMed ID: 19191678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
    Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
    J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
    Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S
    Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
    Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
    Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
    Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
    Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
    Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
    J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
    Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
    Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
    Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
    AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.
    Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ
    J Neurovirol; 2016 Aug; 22(4):541-5. PubMed ID: 26727910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
    Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y;
    PLoS One; 2011; 6(6):e20967. PubMed ID: 21738597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
    Diller R; Thompson K
    Optometry; 2007 Feb; 78(2):63-70. PubMed ID: 17258160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART.
    Mascarello M; Lanzafame M; Lattuada E; Concia E; Ferrari S
    J Neurovirol; 2011 Apr; 17(2):196-9. PubMed ID: 21445699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.